Report cover image

Pharmaceuticals in Scandinavia

Publisher MarketLine
Published Sep 12, 2024
Length 38 Pages
SKU # MTLN19382579

Description

Pharmaceuticals in Scandinavia


Summary

Pharmaceuticals in Scandinavia industry profile provides top-line qualitative and quantitative summary information including: market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
  • The Scandinavian pharmaceuticals market registered revenues of $17.4 billion in 2023, representing a compound annual growth rate (CAGR) of 3.4% between 2018 and 2023
  • Sweden dominated the Scandinavian pharmaceuticals market in 2023, accounting for the largest share of 38.1% in 2023.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Scandinavia
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Scandinavia
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Scandinavia pharmaceuticals market with five year forecasts
Reasons to Buy
  • What was the size of the Scandinavia pharmaceuticals market by value in 2023?
  • What will be the size of the Scandinavia pharmaceuticals market in 2028?
  • What factors are affecting the strength of competition in the Scandinavia pharmaceuticals market?
  • How has the market performed over the last five years?
  • What are the main segments that make up Scandinavia's pharmaceuticals market?

Table of Contents

38 Pages
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strategies of the leading players?
7.3. What are the recent developments in the market?
8 Company Profiles
8.1. F. Hoffmann-La Roche Ltd
8.2. Novo Nordisk AS
8.3. H. Lundbeck AS
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Scandinavia pharmaceuticals market value: $ billion, 2018-23
Table 2: Scandinavia pharmaceuticals market geography segmentation: $ billion, 2023
Table 3: Scandinavia pharmaceuticals market value forecast: $ billion, 2023-28
Table 4: F. Hoffmann-La Roche Ltd: key facts
Table 5: F. Hoffmann-La Roche Ltd: Key Employees
Table 6: Novo Nordisk AS: key facts
Table 7: Novo Nordisk AS: Annual Financial Ratios
Table 8: Novo Nordisk AS: Key Employees
Table 9: H. Lundbeck AS: key facts
Table 10: H. Lundbeck AS: Annual Financial Ratios
Table 11: H. Lundbeck AS: Key Employees
Table 12: Scandinavia exchange rate, 2018-23
List of Figures
Figure 1: 220 Laboratories Inc: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Figure 2: 220 Laboratories Inc: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
Figure 3: 220 Laboratories Inc: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us